Karin Eastham, a director at Veracyte, Inc. ($VCYT), sold shares on the open market five times over the past year, totaling $1.42 million. Her most recent sale occurred on December 5, 2025. These transactions rank her 4,169th among 11,678 insiders by sale value, below the average of $8.6 million across about 6.4 transactions per insider. Eastham made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 10000 | $7.94 | 23,554.0000 | 79,946,386 | 73.78% | 0.01% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 12808 | $45.84 | 14,354.0000 | 79,946,386 | 47.15% | 0.02% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 6392 | $44.52 | 27,162.0000 | 79,946,386 | 19.05% | 0.01% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 10000 | $7.60 | 33,554.0000 | 79,946,386 | 42.46% | 0.01% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 79,946,386 | 100.00% | 0.01% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 79,946,386 | 100.00% | 0.01% |
| Dec. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 800 | $46.59 | 13,554.0000 | 79,946,386 | 5.57% | 0.00% |
| Nov. 5, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 9674 | $40.02 | 13,554.0000 | 79,946,386 | 41.65% | 0.01% |
| June 18, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | A | Common Stock | 9321 | $0.00 | 23,228.0000 | 78,163,217 | 67.02% | 0.01% |
| June 13, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 4590 | $26.66 | 13,907.0000 | 78,163,217 | 24.81% | 0.01% |
| May 16, 2025 | Personalis, Inc. | $PSNL | EASTHAM KARIN | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 88,263,269 | 9999.99% | 0.06% |
| Jan. 2, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 4691 | $40.50 | 18,497.0000 | 78,163,217 | 20.23% | 0.01% |
| Jan. 2, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 10000 | $5.28 | 28,497.0000 | 78,163,217 | 54.06% | 0.01% |
| Jan. 2, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 5309 | $40.12 | 23,188.0000 | 78,163,217 | 18.63% | 0.01% |
| Jan. 2, 2025 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 78,163,217 | 100.00% | 0.01% |
| Nov. 19, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 10125 | $38.76 | 18,497.0000 | 78,465,000 | 35.37% | 0.01% |
| Nov. 19, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 1600 | $36.77 | 31,628.0000 | 78,465,000 | 4.82% | 0.00% |
| Nov. 19, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 3006 | $37.77 | 28,622.0000 | 78,465,000 | 9.50% | 0.00% |
| July 16, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 7500 | $25.00 | 33,228.0000 | 72,644,487 | 18.41% | 0.01% |
| June 13, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | A | Common Stock | 11473 | $0.00 | 40,728.0000 | 72,644,487 | 39.22% | 0.02% |
| June 11, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 3870 | $20.59 | 29,255.0000 | 72,644,487 | 11.68% | 0.01% |
| June 7, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 2500 | $20.97 | 33,125.0000 | 72,644,487 | 7.02% | 0.00% |
| June 7, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 2500 | $10.41 | 35,625.0000 | 72,644,487 | 7.55% | 0.00% |
| June 7, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 2500 | $0.00 | 7,500.0000 | 72,644,487 | 25.00% | 0.00% |
| May 17, 2024 | Personalis, Inc. | $PSNL | EASTHAM KARIN | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 10000 | $21.65 | 33,125.0000 | 72,644,487 | 23.19% | 0.01% |
| April 1, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 10000 | $13.19 | 43,125.0000 | 72,644,487 | 30.19% | 0.01% |
| April 1, 2024 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 10000 | $13.19 | 0.0000 | 72,644,487 | 100.00% | 0.01% |
| June 9, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | A | Common Stock | 9674 | $0.00 | 33,125.0000 | 71,549,204 | 41.25% | 0.01% |
| March 16, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 18750 | $22.78 | 23,451.0000 | 71,549,204 | 44.43% | 0.03% |
| March 16, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 18750 | $12.12 | 42,201.0000 | 71,549,204 | 79.95% | 0.03% |
| March 16, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 18750 | $0.00 | 0.0000 | 71,549,204 | 100.00% | 0.03% |
| Feb. 28, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 18,750.0000 | 71,549,204 | 34.78% | 0.01% |
| Feb. 28, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | M | Common Stock | 10000 | $12.12 | 33,451.0000 | 71,549,204 | 42.64% | 0.01% |
| Feb. 28, 2023 | VERACYTE, INC. | $VCYT | EASTHAM KARIN | Director | S | Common Stock | 10000 | $25.00 | 23,451.0000 | 71,549,204 | 29.89% | 0.01% |
| Jan. 13, 2023 | GERON CORP | $GERN | EASTHAM KARIN | Director | M | Common Stock | 35000 | $1.10 | 109,047.0000 | 380,784,846 | 47.27% | 0.01% |
| Jan. 13, 2023 | GERON CORP | $GERN | EASTHAM KARIN | Director | M | Stock Options (right to buy) | 35000 | $0.00 | 0.0000 | 380,784,846 | 100.00% | 0.01% |